☰

cached image

William T. Harris, M.D. - Publications

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Oates GR, Harris WT, Gutierrez HH, Mims C, Rutland SB, Ott C, Niranjan SJ, Scarinci IC, Walley SC. Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation. Pediatric Pulmonology. PMID 32511883 DOI: 10.1002/Ppul.24879  0.312
2020 Oates GR, Baker E, Rowe SM, Gutierrez HH, Schechter MS, Morgan W, Harris WT. Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32081643 DOI: 10.1016/J.Jcf.2020.02.004  0.383
2020 Oates G, Baker E, Rowe S, Rutland S, Harris W. WS13.3 Tobacco smoke exposure limits the benefit of Symdeko® in paediatric cystic fibrosis patients: Cystic Fibrosis Foundation Patient Registry analysis Journal of Cystic Fibrosis. 19. DOI: 10.1016/S1569-1993(20)30235-6  0.348
2019 Oates GR, Harris WT, Rowe SM, Solomon GM, Dey S, Zhu A, Hoover WC, Gutierrez HH. Area Deprivation as a Risk Factor for Methicillin-resistant Staphylococcus aureus Infection in Pediatric Cystic Fibrosis. The Pediatric Infectious Disease Journal. PMID 31568067 DOI: 10.1097/Inf.0000000000002419  0.34
2019 Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC. An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31053538 DOI: 10.1016/J.Jcf.2019.03.009  0.331
2019 Nicola T, Kabir FL, Coric T, Wall SB, Zhang W, James M, MacEwen M, Ren C, Halloran B, Ambalavanan N, Harris WT. CFTR dysfunction increases endoglin and TGF-β signaling in airway epithelia. Physiological Reports. 7: e13977. PMID 30806029 DOI: 10.14814/Phy2.13977  0.346
2019 Oates GR, Ott C, Niranjan S, Harris WT, Gutierrez HH, Scarinci IC. P420 Reducing tobacco smoke exposure in paediatric cystic fibrosis: a qualitative examination of caregivers' and clinicians perspectives Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30712-X  0.3
2018 Oates GR, Zhu A, Stepanikova I, Thomas L, Gamble S, Mims C, Gutierrez H, Harris WT. WS05.2 Impact of tobacco smoke exposure on pulmonary function in paediatric cystic fibrosis patients Journal of Cystic Fibrosis. 17. DOI: 10.1016/S1569-1993(18)30144-9  0.345
2017 Lutful Kabir F, Ambalavanan N, Liu G, Li P, Solomon GM, Lal CV, Mazur M, Halloran B, Szul T, Gerthoffer WT, Rowe SM, Harris WT. microRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia. American Journal of Respiratory and Critical Care Medicine. PMID 29232160 DOI: 10.1164/Rccm.201704-0732Oc  0.314
2017 Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, et al. Airway microbiota across age and disease spectrum in cystic fibrosis. The European Respiratory Journal. 50. PMID 29146601 DOI: 10.1183/13993003.00832-2017  0.388
2016 Harris WT, Boyd JT, McPhail GL, Brody AS, Szczesniak RD, Korbee LL, Baker ML, Clancy JP. Constrictive Bronchiolitis in Adolescents with Cystic Fibrosis with Refractory Pulmonary Decline. Annals of the American Thoracic Society. PMID 27684511 DOI: 10.1513/Annalsats.201412-594Oc  0.359
2016 Britton LJ, Oates GR, Oster RA, Self ST, Troxler RB, Hoover WC, Gutierrez HH, Harris WT. Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening. Pediatric Pulmonology. PMID 27556254 DOI: 10.1002/Ppul.23536  0.366
2015 Oates GR, Stepanikova I, Gamble S, Gutierrez HH, Harris WT. Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes. Pediatric Pulmonology. PMID 26436321 DOI: 10.1002/Ppul.23317  0.359
2015 Downes KJ, Patil NR, Rao MB, Koralkar R, Harris WT, Clancy JP, Goldstein SL, Askenazi DJ. Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis. Pediatric Nephrology (Berlin, Germany). PMID 25912993 DOI: 10.1007/S00467-015-3097-3  0.304
2015 Bratcher PE, Rowe SM, Reeves G, Roberts T, Szul T, Harris WT, Tirouvanziam R, Gaggar A. Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 25769931 DOI: 10.1016/J.Jcf.2015.02.010  0.303
2014 Sun H, Harris WT, Kortyka S, Kotha K, Ostmann AJ, Rezayat A, Sridharan A, Sanders Y, Naren AP, Clancy JP. Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia. Plos One. 9: e106842. PMID 25268501 DOI: 10.1371/Journal.Pone.0106842  0.317
2013 Harris WT, Kelly DR, Zhou Y, Wang D, MacEwen M, Macewen M, Hagood JS, Clancy JP, Ambalavanan N, Sorscher EJ. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. Plos One. 8: e70196. PMID 23950911 DOI: 10.1371/Journal.Pone.0070196  0.387
2013 Harris WT, Kelly DR, Zhou Y, Wang D, MacEwen M, Hagood JS, Clancy JP, Ambalavanan N, Sorscher EJ. Correction: Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease Plos One. 8. DOI: 10.1371/Annotation/D0132De3-56Ca-4258-9119-Bdab0Ceb2Cff  0.328
2013 Peterson-Carmichael SL, Harris WT, Goel R, Noah TL, Johnson R, Leigh MW, Davis SD. Erratum: Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis Pediatric Pulmonology. 48: 631-631. DOI: 10.1002/Ppul.22821  0.357
2011 Harris WT, Muhlebach MS, Oster RA, Knowles MR, Clancy JP, Noah TL. Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatric Pulmonology. 46: 688-95. PMID 21337732 DOI: 10.1002/Ppul.21430  0.4
2010 Noah TL, Ivins SS, Abode KA, Stewart PW, Michelson PH, Harris WT, Henry MM, Leigh MW. Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas. Pediatric Pulmonology. 45: 281-90. PMID 20146365 DOI: 10.1002/Ppul.21176  0.352
2009 Harris WT, Muhlebach MS, Oster RA, Knowles MR, Noah TL. Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatric Pulmonology. 44: 1057-64. PMID 19830844 DOI: 10.1002/Ppul.21079  0.378
2009 Peterson-Carmichael SL, Harris WT, Goel R, Noah TL, Johnson R, Leigh MW, Davis SD. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatric Pulmonology. 44: 503-11. PMID 19382221 DOI: 10.1002/Ppul.21044  0.394
2006 Saito J, Harris WT, Gelfond J, Noah TL, Leigh MW, Johnson R, Davis SD. Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatric Pulmonology. 41: 709-19. PMID 16779841 DOI: 10.1002/Ppul.20387  0.328
Show low-probability matches.